Juvenile Detention to Community Life
DTC
Facilitating Adolescent Offenders' Reintegration From Juvenile Detention to Community Life (DTC)
1 other identifier
interventional
154
1 country
5
Brief Summary
The fundamental objective of the proposed study is to develop and test an innovative two-stage, cross-systems family-based intervention for substance abusing juvenile offenders. The first stage of the experimental treatment is provided for youths in juvenile detention settings. Stage two of the intervention occurs after the offender is released to the community. Participants are randomized to one of two study conditions: the cross-systems family-based intervention (Multidimensional Family Therapy-Cross Systems (MDFT-CS), or 2) Enhanced Services as Usual (ESAU). Both conditions incorporate HIV prevention in detention and we will also examine the effects of a family-based HIV/STD prevention module beyond the impact of a standard HIV/STD education intervention delivered in detention by including ongoing HIV/STD intervention in MDFT-CS following release from detention. There are five aims of the proposed study. These aims relate to: 1) Intervention development and implementation; 2) Clinical effectiveness; 3) Impact of HIV/AIDS/STD prevention; 4) Comparative benefit-costs; and 5) Systems-level impact
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2006
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 25, 2013
CompletedFirst Posted
Study publicly available on registry
July 29, 2013
CompletedMay 22, 2014
May 1, 2014
2.4 years
July 25, 2013
May 21, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Substance use
Timeline Follow-Back Method of Drug and Alcohol Use, Urine analyses for Drug Use, Personal Experiences Inventory and the Adolescent Diagnostic Interview-Light will be used to measure substance use.
Release from detention through the 42-month follow-up
Secondary Outcomes (2)
Delinquency
Release from detention through the 42-month follow-up
Sexual Risk Behaviors
Release from detention through the 42-month follow-up
Study Arms (2)
Multidimensional Family Therapy Cross-Systems
EXPERIMENTALIn Stage 1 (in detention) Multidimensional Family Therapy Cross-Systems (MDFT-CS) consists of two major components: standard initial/engagement work with parents in the home and with adolescents in detention, plus a state-of-the-art HIV education prevention module. In Stage 2, MDFT-CS includes the standard MDFT components: 1) interventions with the adolescent, 2) interventions with the parent, 3) interventions to improve the parent-adolescent relationship, 4) interventions with other family members, and 5) interventions with external systems.
Enhanced Services as Usual
OTHERIn Stage 1 (in detention) ESAU includes two major components: standard drug treatment services delivered by detention staff, and state-of-the-art HIV education prevention intervention. In Stage 2, community drug treatment providers deliver high quality drug treatment on an outpatient basis.
Interventions
Standard initial/engagement work in the home and detention, plus a state-of-the-art HIV education prevention module as well as standard MDFT which assesses and intervenes in five domains: 1) Interventions with the adolescent, 2) interventions with the parent, 3) interventions to improve the parent-adolescent relationship, 4) interventions with other family members, and 5) interventions with external systems.
Standard drug treatment services in detention and state-of-the-art HIV education prevention intervention, as well as outpatient drug treatment provided by community drug treatment providers
Eligibility Criteria
You may qualify if:
- Be between the ages of 13 and 17
- Be incarcerated in a juvenile detention facility at intake
- Endorse substance abuse problems on the MAYSI or other intake forms
- Have at least one parent figure willing/able to participate in the intervention and research assessments
- Provide informed consent to participate in the study
You may not qualify if:
- Mental retardation or pervasive developmental disorders
- Psychotic features
- Current suicidality defined as Ideation + Plan + High intention to carry out plan
- High risk to receive long-term residential placement directly from detention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Pinellas Juvenile Detention Center
Clearwater, Florida, 33760, United States
Operation PAR Inc.
Largo, Florida, 33771, United States
Here's Help, Inc.
Miami, Florida, 33054, United States
University of Miami Miller School of Medicine
Miami, Florida, 33136, United States
Miami-Dade Juvenile Detention Center
Miami, Florida, 33142, United States
Related Publications (4)
Liddle HA, Dakof GA, Henderson C, Rowe C. Implementation outcomes of Multidimensional Family Therapy-Detention to Community: a reintegration program for drug-using juvenile detainees. Int J Offender Ther Comp Criminol. 2011 Jun;55(4):587-604. doi: 10.1177/0306624X10366960. Epub 2010 Apr 28.
PMID: 20427547BACKGROUNDMarvel F, Rowe CL, Colon-Perez L, DiClemente RJ, Liddle HA. Multidimensional family therapy HIV/STD risk-reduction intervention: an integrative family-based model for drug-involved juvenile offenders. Fam Process. 2009 Mar;48(1):69-84. doi: 10.1111/j.1545-5300.2009.01268.x.
PMID: 19378646BACKGROUNDRowe CL, Wang W, Greenbaum P, Liddle HA. Predicting HIV/STD risk level and substance use disorders among incarcerated adolescents. J Psychoactive Drugs. 2008 Dec;40(4):503-12. doi: 10.1080/02791072.2008.10400656.
PMID: 19283954BACKGROUNDRowe CL, Alberga L, Dakof GA, Henderson CE, Ungaro R, Liddle HA. Family-Based HIV and Sexually Transmitted Infection Risk Reduction for Drug-Involved Young Offenders: 42-Month Outcomes. Fam Process. 2016 Jun;55(2):305-20. doi: 10.1111/famp.12206. Epub 2016 Feb 16.
PMID: 26879671DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Howard A Liddle, EdD
University of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 25, 2013
First Posted
July 29, 2013
Study Start
April 1, 2006
Primary Completion
September 1, 2008
Study Completion
December 1, 2011
Last Updated
May 22, 2014
Record last verified: 2014-05